MTNB · Matinas BioPharma Holdings, Inc.
$0.23
+0.00 (+0.43%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not believe that our existing cash and cash equivalents will be sufficient to fund our operating expenses and capital requirements for a period of at least the next twelve months from the filing date of this Quarterly Report. As a result, substantial doubt exists about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.44M
Shares
14.69M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 37,417 | 1,051,716 | 1,089,133 | 61.8% |
| 2026-06-29 | 7,008 | 151,017 | 158,025 | 90.4% |
| 2026-06-22 | 1,410 | 222,757 | 224,167 | 82.8% |
| 2026-06-15 | 6,107 | 227,137 | 233,244 | 73.9% |
| 2026-06-08 | 8,261 | 234,662 | 242,923 | 77.3% |
| 2026-06-01 | 5,075 | 408,028 | 413,103 | 85.2% |
| 2026-05-25 | 7,237 | 180,781 | 188,018 | 77.8% |
| 2026-05-18 | 342,064 | 3,754,984 | 4,097,048 | 60.6% |
| 2026-05-11 | 3,168 | 164,038 | 167,206 | 88.4% |
| 2026-05-04 | 2,363 | 79,284 | 81,647 | 71.1% |
| 2026-04-27 | 2,993 | 110,843 | 113,836 | 74.9% |
| 2026-04-20 | 5,217 | 150,161 | 155,378 | 71.2% |
| 2026-04-13 | 6,773 | 183,989 | 190,762 | 84.2% |
| 2026-04-06 | 3,099 | 65,126 | 68,225 | 69.3% |
| 2026-03-30 | 4,353 | 52,001 | 56,354 | 55.5% |
| 2026-03-23 | 5,503 | 120,627 | 126,130 | 74.3% |
| 2026-03-16 | 1,434 | 57,046 | 58,480 | 64.1% |
| 2026-03-09 | 2,753 | 40,419 | 43,172 | 74.6% |
| 2026-03-02 | 5,122 | 54,112 | 59,234 | 73.4% |
| 2026-02-23 | 56,472 | 45,436 | 101,908 | 76.4% |
| 2026-02-16 | 3,178 | 22,127 | 25,305 | 67.1% |
| 2026-02-09 | 6,302 | 56,902 | 63,204 | 60.4% |
| 2026-02-02 | 8,633 | 154,880 | 163,513 | 68.2% |
| 2026-01-26 | 6,810 | 121,037 | 127,847 | 54.5% |
| 2026-01-19 | 9,318 | 137,849 | 147,167 | 64.2% |
| 2026-01-12 | 5,197 | 111,922 | 117,119 | 62.9% |
| 2026-01-05 | 4,907 | 78,934 | 83,841 | 70.2% |
| 2025-12-29 | 3,618 | 73,378 | 76,996 | 51.3% |
| 2025-12-22 | 1,956 | 95,455 | 97,411 | 64.9% |
| 2025-12-15 | 2,714 | 114,839 | 117,553 | 65.9% |
| 2025-12-08 | 13,652 | 103,163 | 116,815 | 66.4% |
| 2025-12-01 | 6,702 | 96,962 | 103,664 | 70.2% |
| 2025-11-24 | 8,373 | 93,122 | 101,495 | 51.2% |
| 2025-11-17 | 4,204 | 58,319 | 62,523 | 62.3% |
| 2025-11-10 | 2,454 | 32,629 | 35,083 | 65.9% |
| 2025-11-03 | 2,426 | 60,686 | 63,112 | 64.1% |
| 2025-10-27 | 6,141 | 81,960 | 88,101 | 59.0% |
| 2025-10-20 | 4,976 | 73,793 | 78,769 | 59.4% |
| 2025-10-13 | 9,317 | 102,646 | 111,963 | 61.9% |
| 2025-10-06 | 8,981 | 148,955 | 157,936 | 58.6% |
| 2025-09-29 | 2,270 | 98,089 | 100,359 | 61.5% |
| 2025-09-22 | 5,432 | 261,585 | 267,017 | 51.4% |
| 2025-09-15 | 6,521 | 103,151 | 109,672 | 61.1% |
| 2025-09-08 | 25,944 | 118,588 | 144,532 | 56.7% |
| 2025-09-01 | 25,553 | 179,585 | 205,138 | 68.6% |
| 2025-08-25 | 30,857 | 192,951 | 223,808 | 56.7% |
| 2025-08-18 | 282,146 | 1,829,157 | 2,111,303 | 59.2% |
Showing 1–47 of 47 weeks
Key facts
CIK
1582554
CUSIP
576810303
13F (30d)
24 filings
24 filers
Visit website
Investor relations